Distalmotion Secures Up to $70 Million Term Loan from Perceptive Advisors

Distalmotion has entered into a senior secured term loan facility of up to $70 million with Perceptive Advisors, a leading global healthcare investment firm. The financing provides additional capital to support Distalmotion's continued penetration of the US ambulatory surgery center (ASC) market and further development of the DEXTER Robotic Surgery System and its instrument portfolio.

With surgical care migrating toward outpatient settings, ASCs are seeking robotic solutions designed around their operating realities. DEXTER combines a small, mobile footprint with flexible workflows to enable ASCs to introduce robotic surgery without the infrastructure required by traditional platforms.

Sam Chawla, Portfolio Manager at Perceptive, stated:

"Partnering with Distalmotion aligns with our investment focus on high-impact and disruptive healthcare innovation. DEXTER is purpose-built for the ongoing shift of high-volume surgery to the ASC, where efficiency is paramount."

The financing builds on commercial momentum in the US, where DEXTER is cleared for major soft tissue outpatient procedures including cholecystectomy, hernia repair, and hysterectomy.

Greg Roche, CEO of Distalmotion, stated:

"Perceptive brings deep healthcare investment expertise and a strong understanding of the technologies shaping the future of care delivery. This financing gives us additional capital to accelerate our US growth strategy, strengthen our commercial presence, and continue to optimize DEXTER for ASC patients, surgeons, and administrators."

DEXTER features a sterile console positioning surgeons close to patients, allowing seamless transitions between laparoscopic and robotic techniques. Headquartered in Lausanne, Switzerland, with a US office in Cleveland, Ohio, Distalmotion continues expanding access to minimally invasive surgical technology across international markets.